-
Collegium Pharmaceutical (NASDAQ:COLL) Rating Increased to Strong-Buy at StockNews.com
Source: Buzz FX / 15 Oct 2024 23:22:12 America/New_York
Collegium Pharmaceutical (NASDAQ:COLL) Rating Increased to Strong-Buy at StockNews.com Written by MarketBeat October 15, 2024 Share Link copied to clipboard. Collegium Pharmaceutical ( NASDAQ:COLL - Get Free Report ) was upgraded by equitie
Read more...